NCT00024687View on ClinicalTrials.gov

Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: IV Infusion QOD x Six Doses

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 30, 2000

Conditions
Neoplasms
Interventions
DRUG

SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin

Trial Locations (1)

20892

NCI/NIH, Bethesda

Sponsors
All Listed Sponsors
lead

INSYS Therapeutics Inc

INDUSTRY

NCT00024687 - Study of SS1(dsFv)-PE38 (SS1P) Anti-Mesothelin Immunotoxin in Advanced Malignancies: IV Infusion QOD x Six Doses | Biotech Hunter | Biotech Hunter